Skip to main content
. 2019 Nov 17;71(9):2314–2322. doi: 10.1093/cid/ciz1105

Table 3.

Performance of Assays Under Consideration for Detection of Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis

Site and Infection PPA (95% CI) NPA (95% CI) PPVa (95% CI) NPVa (95% CI) Positive LR (95% CI) Negative LR (95% CI)
Pharynx, NG
 Assay 1 94.7 (90.7–97.0) 98.8 (98.2–99.1) 87.1 (82.0–90.8) 99.5 (99.2–99.7) 77 (54–111) 0.05 (.03–.10)
 Assay 2 95.1 (91.3–97.3) 98.8 (98.3–99.2) 88.2 (83.3–91.8) 99.6 (99.2–99.8) 78 (54–112) 0.05 (.03–.09)
 Assay 3 84.8 (79.4–89.0) 99.5 (99.2–99.7) 94.2 (89.9–96.7) 98.7 (98.1–99.0) 183 (101–330) 0.15 (.11–.21)
Rectum, NG
 Assay 1 91.2 (86.5–94.4) 99.6 (99.3–99.8) 95.4 (91.5–97.6) 99.3 (98.8–99.5) 238 (124–457) 0.08 (.05–.15)
 Assay 2 96.5 (92.9–98.3) 99.2 (98.8–99.5) 92.8 (88.4–95.6) 99.8 (99.5–99.9) 127 (80–202) 0.04 (.02–.07)
 Assay 3 88.3 (83.2–92.0) 99.6 (99.2–99.8) 94.8 (90.6–97.1) 99.0 (98.5–99.3) 205 (110–381) 0.12 (.08–.17)
Pharynx, CT
 Assay 1 95.9 (86.3–98.9) 99.7 (99.4–99.8) 85.5 (73.8–92.4) 99.9 (99.7–100.0) 303 (151–606) 0.04 (.01–.16)
 Assay 2 88.2 (76.6–94.5) 99.7 (99.4–99.8) 84.9 (72.9–92.1) 99.8 (99.5–99.9) 279 (139–562) 0.12 (.06–.25)
 Assay 3 84.0 (71.5–91.7) 99.8 (99.5–99.9) 89.4 (77.4–95.4) 99.7 (99.4–99.8) 354 (158–794) 0.16 (.08–.30)
Rectum, CT
 Assay 1 86.0 (80.9–89.9) 99.3 (98.9–99.6) 92.5 (88.1–95.3) 98.6 (98.1–99.0) 124 (76–203) 0.14 (.10–.19)
 Assay 2 88.7 (83.9–92.3) 98.7 (98.2–99.1) 88.7 (83.9–92.3) 99.1 (98.7–99.4) 70 (49–100) 0.11 (.08–.17)
 Assay 3 83.0 (77.5–87.2) 99.1 (98.6–99.4) 90.0 (85.3–93.4) 98.3 (97.7–98.8) 91 (59–140) 0.17 (.13–.23)

Abbreviations: CI, confidence interval; CT, Chlamydia trachomatis; LR, likelihood ratio; NG, Neisseria gonorrhoeae; NPA, negative percent agreement; NPV, negative predictive value; PPA, positive percent agreement; PPV, positive predictive value.

aPPVs and NPVs were calculated based on the positivity observed in this study.